nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—Ageusia—Cisplatin—lung cancer	0.0139	0.0187	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Crizotinib—lung cancer	0.0132	0.0177	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Gefitinib—lung cancer	0.0106	0.0142	CcSEcCtD
Methylscopolamine bromide—Ageusia—Docetaxel—lung cancer	0.0106	0.0142	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Pemetrexed—lung cancer	0.0105	0.014	CcSEcCtD
Methylscopolamine bromide—Constipation—Crizotinib—lung cancer	0.00978	0.0131	CcSEcCtD
Methylscopolamine bromide—Constipation—Pemetrexed—lung cancer	0.00894	0.012	CcSEcCtD
Methylscopolamine bromide—Constipation—Gefitinib—lung cancer	0.00888	0.0119	CcSEcCtD
Methylscopolamine bromide—Confusional state—Teniposide—lung cancer	0.00854	0.0115	CcSEcCtD
Methylscopolamine bromide—Urticaria—Pemetrexed—lung cancer	0.0083	0.0111	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Teniposide—lung cancer	0.00826	0.0111	CcSEcCtD
Methylscopolamine bromide—Urticaria—Gefitinib—lung cancer	0.00825	0.0111	CcSEcCtD
Methylscopolamine bromide—Asthenia—Crizotinib—lung cancer	0.00821	0.011	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Irinotecan—lung cancer	0.00784	0.0105	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Pemetrexed—lung cancer	0.0077	0.0103	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Gefitinib—lung cancer	0.00765	0.0103	CcSEcCtD
Methylscopolamine bromide—Dizziness—Crizotinib—lung cancer	0.00756	0.0101	CcSEcCtD
Methylscopolamine bromide—Asthenia—Pemetrexed—lung cancer	0.0075	0.0101	CcSEcCtD
Methylscopolamine bromide—Asthenia—Gefitinib—lung cancer	0.00745	0.01	CcSEcCtD
Methylscopolamine bromide—Vomiting—Crizotinib—lung cancer	0.00727	0.00976	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Teniposide—lung cancer	0.00698	0.00936	CcSEcCtD
Methylscopolamine bromide—Dizziness—Pemetrexed—lung cancer	0.00691	0.00927	CcSEcCtD
Methylscopolamine bromide—Nausea—Crizotinib—lung cancer	0.00679	0.00912	CcSEcCtD
Methylscopolamine bromide—Urticaria—Teniposide—lung cancer	0.00673	0.00902	CcSEcCtD
Methylscopolamine bromide—Vomiting—Pemetrexed—lung cancer	0.00665	0.00892	CcSEcCtD
Methylscopolamine bromide—Ageusia—Doxorubicin—lung cancer	0.00661	0.00887	CcSEcCtD
Methylscopolamine bromide—Vomiting—Gefitinib—lung cancer	0.0066	0.00886	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Paclitaxel—lung cancer	0.00639	0.00858	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Topotecan—lung cancer	0.00628	0.00842	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Teniposide—lung cancer	0.00624	0.00837	CcSEcCtD
Methylscopolamine bromide—Nausea—Pemetrexed—lung cancer	0.00621	0.00833	CcSEcCtD
Methylscopolamine bromide—Nausea—Gefitinib—lung cancer	0.00617	0.00828	CcSEcCtD
Methylscopolamine bromide—Asthenia—Teniposide—lung cancer	0.00608	0.00815	CcSEcCtD
Methylscopolamine bromide—Palpitations—Vinorelbine—lung cancer	0.00581	0.0078	CcSEcCtD
Methylscopolamine bromide—Insomnia—Erlotinib—lung cancer	0.00562	0.00753	CcSEcCtD
Methylscopolamine bromide—Constipation—Vinblastine—lung cancer	0.00552	0.00741	CcSEcCtD
Methylscopolamine bromide—Vomiting—Teniposide—lung cancer	0.00538	0.00722	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Vinorelbine—lung cancer	0.00537	0.0072	CcSEcCtD
Methylscopolamine bromide—Constipation—Topotecan—lung cancer	0.00537	0.0072	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Vinblastine—lung cancer	0.00532	0.00714	CcSEcCtD
Methylscopolamine bromide—Constipation—Erlotinib—lung cancer	0.00531	0.00712	CcSEcCtD
Methylscopolamine bromide—Headache—Teniposide—lung cancer	0.0053	0.00712	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Vinorelbine—lung cancer	0.00524	0.00703	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Topotecan—lung cancer	0.00517	0.00694	CcSEcCtD
Methylscopolamine bromide—Nausea—Teniposide—lung cancer	0.00503	0.00675	CcSEcCtD
Methylscopolamine bromide—Urticaria—Topotecan—lung cancer	0.00499	0.00669	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Vinblastine—lung cancer	0.00476	0.00639	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Cisplatin—lung cancer	0.00464	0.00623	CcSEcCtD
Methylscopolamine bromide—Asthenia—Vinblastine—lung cancer	0.00464	0.00622	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Topotecan—lung cancer	0.00462	0.0062	CcSEcCtD
Methylscopolamine bromide—Constipation—Vinorelbine—lung cancer	0.00459	0.00616	CcSEcCtD
Methylscopolamine bromide—Asthenia—Topotecan—lung cancer	0.0045	0.00604	CcSEcCtD
Methylscopolamine bromide—Confusional state—Irinotecan—lung cancer	0.00446	0.00599	CcSEcCtD
Methylscopolamine bromide—Asthenia—Erlotinib—lung cancer	0.00446	0.00598	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Irinotecan—lung cancer	0.00443	0.00594	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Vinorelbine—lung cancer	0.00442	0.00594	CcSEcCtD
Methylscopolamine bromide—Tension—Paclitaxel—lung cancer	0.00434	0.00583	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Gemcitabine—lung cancer	0.00431	0.00579	CcSEcCtD
Methylscopolamine bromide—Nervousness—Paclitaxel—lung cancer	0.0043	0.00577	CcSEcCtD
Methylscopolamine bromide—Dizziness—Vinblastine—lung cancer	0.00427	0.00573	CcSEcCtD
Methylscopolamine bromide—Urticaria—Vinorelbine—lung cancer	0.00427	0.00572	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Paclitaxel—lung cancer	0.00417	0.00559	CcSEcCtD
Methylscopolamine bromide—Dizziness—Topotecan—lung cancer	0.00415	0.00557	CcSEcCtD
Methylscopolamine bromide—Vomiting—Vinblastine—lung cancer	0.00411	0.00551	CcSEcCtD
Methylscopolamine bromide—Dizziness—Erlotinib—lung cancer	0.00411	0.00551	CcSEcCtD
Methylscopolamine bromide—Headache—Vinblastine—lung cancer	0.00405	0.00543	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Cisplatin—lung cancer	0.00402	0.00539	CcSEcCtD
Methylscopolamine bromide—Insomnia—Irinotecan—lung cancer	0.004	0.00537	CcSEcCtD
Methylscopolamine bromide—Vomiting—Topotecan—lung cancer	0.00399	0.00535	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Vinorelbine—lung cancer	0.00396	0.00531	CcSEcCtD
Methylscopolamine bromide—Vomiting—Erlotinib—lung cancer	0.00395	0.0053	CcSEcCtD
Methylscopolamine bromide—Somnolence—Irinotecan—lung cancer	0.00394	0.00528	CcSEcCtD
Methylscopolamine bromide—Headache—Topotecan—lung cancer	0.00393	0.00527	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Cisplatin—lung cancer	0.00392	0.00526	CcSEcCtD
Methylscopolamine bromide—Palpitations—Paclitaxel—lung cancer	0.00391	0.00525	CcSEcCtD
Methylscopolamine bromide—Insomnia—Gemcitabine—lung cancer	0.0039	0.00523	CcSEcCtD
Methylscopolamine bromide—Headache—Erlotinib—lung cancer	0.00389	0.00522	CcSEcCtD
Methylscopolamine bromide—Asthenia—Vinorelbine—lung cancer	0.00385	0.00517	CcSEcCtD
Methylscopolamine bromide—Nausea—Vinblastine—lung cancer	0.00384	0.00515	CcSEcCtD
Methylscopolamine bromide—Somnolence—Gemcitabine—lung cancer	0.00383	0.00514	CcSEcCtD
Methylscopolamine bromide—Constipation—Irinotecan—lung cancer	0.00379	0.00508	CcSEcCtD
Methylscopolamine bromide—Nausea—Topotecan—lung cancer	0.00373	0.005	CcSEcCtD
Methylscopolamine bromide—Confusional state—Etoposide—lung cancer	0.00371	0.00498	CcSEcCtD
Methylscopolamine bromide—Constipation—Gemcitabine—lung cancer	0.00369	0.00495	CcSEcCtD
Methylscopolamine bromide—Nausea—Erlotinib—lung cancer	0.00369	0.00495	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Paclitaxel—lung cancer	0.00368	0.00494	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Etoposide—lung cancer	0.00368	0.00494	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Irinotecan—lung cancer	0.00365	0.0049	CcSEcCtD
Methylscopolamine bromide—Confusional state—Paclitaxel—lung cancer	0.00364	0.00488	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Paclitaxel—lung cancer	0.00361	0.00484	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Etoposide—lung cancer	0.00359	0.00482	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Methotrexate—lung cancer	0.00357	0.00479	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Gemcitabine—lung cancer	0.00355	0.00477	CcSEcCtD
Methylscopolamine bromide—Dizziness—Vinorelbine—lung cancer	0.00355	0.00476	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Paclitaxel—lung cancer	0.00352	0.00473	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Methotrexate—lung cancer	0.00346	0.00464	CcSEcCtD
Methylscopolamine bromide—Vomiting—Vinorelbine—lung cancer	0.00341	0.00458	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Doxorubicin—lung cancer	0.00338	0.00454	CcSEcCtD
Methylscopolamine bromide—Headache—Vinorelbine—lung cancer	0.00336	0.00451	CcSEcCtD
Methylscopolamine bromide—Palpitations—Docetaxel—lung cancer	0.00331	0.00445	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Cisplatin—lung cancer	0.00331	0.00444	CcSEcCtD
Methylscopolamine bromide—Somnolence—Etoposide—lung cancer	0.00327	0.00439	CcSEcCtD
Methylscopolamine bromide—Insomnia—Paclitaxel—lung cancer	0.00327	0.00438	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Irinotecan—lung cancer	0.00326	0.00438	CcSEcCtD
Methylscopolamine bromide—Somnolence—Paclitaxel—lung cancer	0.00321	0.00431	CcSEcCtD
Methylscopolamine bromide—Nausea—Vinorelbine—lung cancer	0.00319	0.00428	CcSEcCtD
Methylscopolamine bromide—Asthenia—Irinotecan—lung cancer	0.00318	0.00426	CcSEcCtD
Methylscopolamine bromide—Constipation—Etoposide—lung cancer	0.00315	0.00423	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Docetaxel—lung cancer	0.00312	0.00419	CcSEcCtD
Methylscopolamine bromide—Asthenia—Gemcitabine—lung cancer	0.00309	0.00415	CcSEcCtD
Methylscopolamine bromide—Constipation—Paclitaxel—lung cancer	0.00309	0.00414	CcSEcCtD
Methylscopolamine bromide—Confusional state—Docetaxel—lung cancer	0.00309	0.00414	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Docetaxel—lung cancer	0.00306	0.00411	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Etoposide—lung cancer	0.00304	0.00407	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Doxorubicin—lung cancer	0.003	0.00402	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Docetaxel—lung cancer	0.00299	0.00401	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Paclitaxel—lung cancer	0.00298	0.00399	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Cisplatin—lung cancer	0.00296	0.00397	CcSEcCtD
Methylscopolamine bromide—Dizziness—Irinotecan—lung cancer	0.00293	0.00393	CcSEcCtD
Methylscopolamine bromide—Urticaria—Etoposide—lung cancer	0.00293	0.00393	CcSEcCtD
Methylscopolamine bromide—Asthenia—Cisplatin—lung cancer	0.00288	0.00387	CcSEcCtD
Methylscopolamine bromide—Urticaria—Paclitaxel—lung cancer	0.00287	0.00385	CcSEcCtD
Methylscopolamine bromide—Vomiting—Irinotecan—lung cancer	0.00282	0.00378	CcSEcCtD
Methylscopolamine bromide—Headache—Irinotecan—lung cancer	0.00277	0.00372	CcSEcCtD
Methylscopolamine bromide—Insomnia—Docetaxel—lung cancer	0.00277	0.00371	CcSEcCtD
Methylscopolamine bromide—Vomiting—Gemcitabine—lung cancer	0.00274	0.00368	CcSEcCtD
Methylscopolamine bromide—Somnolence—Docetaxel—lung cancer	0.00272	0.00365	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Etoposide—lung cancer	0.00271	0.00364	CcSEcCtD
Methylscopolamine bromide—Headache—Gemcitabine—lung cancer	0.0027	0.00363	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Paclitaxel—lung cancer	0.00266	0.00357	CcSEcCtD
Methylscopolamine bromide—Asthenia—Etoposide—lung cancer	0.00264	0.00355	CcSEcCtD
Methylscopolamine bromide—Nausea—Irinotecan—lung cancer	0.00263	0.00353	CcSEcCtD
Methylscopolamine bromide—Constipation—Docetaxel—lung cancer	0.00262	0.00351	CcSEcCtD
Methylscopolamine bromide—Asthenia—Paclitaxel—lung cancer	0.00259	0.00348	CcSEcCtD
Methylscopolamine bromide—Nausea—Gemcitabine—lung cancer	0.00256	0.00344	CcSEcCtD
Methylscopolamine bromide—Vomiting—Cisplatin—lung cancer	0.00256	0.00343	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Methotrexate—lung cancer	0.00255	0.00342	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Docetaxel—lung cancer	0.00252	0.00338	CcSEcCtD
Methylscopolamine bromide—Dizziness—Etoposide—lung cancer	0.00244	0.00327	CcSEcCtD
Methylscopolamine bromide—Dizziness—Paclitaxel—lung cancer	0.00239	0.0032	CcSEcCtD
Methylscopolamine bromide—Nausea—Cisplatin—lung cancer	0.00239	0.0032	CcSEcCtD
Methylscopolamine bromide—Vomiting—Etoposide—lung cancer	0.00234	0.00314	CcSEcCtD
Methylscopolamine bromide—Headache—Etoposide—lung cancer	0.00231	0.0031	CcSEcCtD
Methylscopolamine bromide—Tension—Doxorubicin—lung cancer	0.0023	0.00308	CcSEcCtD
Methylscopolamine bromide—Vomiting—Paclitaxel—lung cancer	0.0023	0.00308	CcSEcCtD
Methylscopolamine bromide—Nervousness—Doxorubicin—lung cancer	0.00227	0.00305	CcSEcCtD
Methylscopolamine bromide—Headache—Paclitaxel—lung cancer	0.00226	0.00304	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Docetaxel—lung cancer	0.00226	0.00303	CcSEcCtD
Methylscopolamine bromide—Confusional state—Methotrexate—lung cancer	0.00222	0.00298	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Methotrexate—lung cancer	0.00221	0.00296	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Doxorubicin—lung cancer	0.00221	0.00296	CcSEcCtD
Methylscopolamine bromide—Asthenia—Docetaxel—lung cancer	0.0022	0.00295	CcSEcCtD
Methylscopolamine bromide—Nausea—Etoposide—lung cancer	0.00219	0.00293	CcSEcCtD
Methylscopolamine bromide—Nausea—Paclitaxel—lung cancer	0.00215	0.00288	CcSEcCtD
Methylscopolamine bromide—Palpitations—Doxorubicin—lung cancer	0.00207	0.00278	CcSEcCtD
Methylscopolamine bromide—Dizziness—Docetaxel—lung cancer	0.00202	0.00272	CcSEcCtD
Methylscopolamine bromide—Insomnia—Methotrexate—lung cancer	0.002	0.00268	CcSEcCtD
Methylscopolamine bromide—Somnolence—Methotrexate—lung cancer	0.00196	0.00263	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Doxorubicin—lung cancer	0.00195	0.00261	CcSEcCtD
Methylscopolamine bromide—Vomiting—Docetaxel—lung cancer	0.00195	0.00261	CcSEcCtD
Methylscopolamine bromide—Confusional state—Doxorubicin—lung cancer	0.00193	0.00258	CcSEcCtD
Methylscopolamine bromide—Headache—Docetaxel—lung cancer	0.00192	0.00257	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Doxorubicin—lung cancer	0.00191	0.00256	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Doxorubicin—lung cancer	0.00186	0.0025	CcSEcCtD
Methylscopolamine bromide—Nausea—Docetaxel—lung cancer	0.00182	0.00244	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Methotrexate—lung cancer	0.00182	0.00244	CcSEcCtD
Methylscopolamine bromide—Urticaria—Methotrexate—lung cancer	0.00175	0.00235	CcSEcCtD
Methylscopolamine bromide—Insomnia—Doxorubicin—lung cancer	0.00173	0.00232	CcSEcCtD
Methylscopolamine bromide—Somnolence—Doxorubicin—lung cancer	0.0017	0.00228	CcSEcCtD
Methylscopolamine bromide—Constipation—Doxorubicin—lung cancer	0.00163	0.00219	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Methotrexate—lung cancer	0.00163	0.00218	CcSEcCtD
Methylscopolamine bromide—Asthenia—Methotrexate—lung cancer	0.00158	0.00212	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Doxorubicin—lung cancer	0.00157	0.00211	CcSEcCtD
Methylscopolamine bromide—Urticaria—Doxorubicin—lung cancer	0.00152	0.00204	CcSEcCtD
Methylscopolamine bromide—Dizziness—Methotrexate—lung cancer	0.00146	0.00196	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Doxorubicin—lung cancer	0.00141	0.00189	CcSEcCtD
Methylscopolamine bromide—Vomiting—Methotrexate—lung cancer	0.0014	0.00188	CcSEcCtD
Methylscopolamine bromide—Headache—Methotrexate—lung cancer	0.00138	0.00185	CcSEcCtD
Methylscopolamine bromide—Asthenia—Doxorubicin—lung cancer	0.00137	0.00184	CcSEcCtD
Methylscopolamine bromide—Nausea—Methotrexate—lung cancer	0.00131	0.00176	CcSEcCtD
Methylscopolamine bromide—Dizziness—Doxorubicin—lung cancer	0.00126	0.00169	CcSEcCtD
Methylscopolamine bromide—Vomiting—Doxorubicin—lung cancer	0.00121	0.00163	CcSEcCtD
Methylscopolamine bromide—Headache—Doxorubicin—lung cancer	0.0012	0.00161	CcSEcCtD
Methylscopolamine bromide—Nausea—Doxorubicin—lung cancer	0.00113	0.00152	CcSEcCtD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—MAP2K1—lung cancer	9.81e-05	0.000385	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3CD—lung cancer	9.74e-05	0.000383	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AVP—lung cancer	9.5e-05	0.000373	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PIK3CB—lung cancer	9.47e-05	0.000372	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AVP—lung cancer	9.47e-05	0.000372	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PIK3CB—lung cancer	9.44e-05	0.000371	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APC—lung cancer	9.42e-05	0.00037	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—KIT—lung cancer	9.42e-05	0.00037	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CG—lung cancer	9.42e-05	0.00037	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—NRAS—lung cancer	9.42e-05	0.00037	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AVP—lung cancer	9.38e-05	0.000368	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PIK3CB—lung cancer	9.35e-05	0.000367	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—EGF—lung cancer	9.31e-05	0.000366	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF1R—lung cancer	9.14e-05	0.000359	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF1R—lung cancer	9.11e-05	0.000358	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CXCL8—lung cancer	9.1e-05	0.000358	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CXCL8—lung cancer	9.07e-05	0.000356	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF1R—lung cancer	9.03e-05	0.000355	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—MAPK3—lung cancer	9.02e-05	0.000354	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CXCL8—lung cancer	8.99e-05	0.000353	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HES1—lung cancer	8.98e-05	0.000353	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—POMC—lung cancer	8.97e-05	0.000352	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HES1—lung cancer	8.95e-05	0.000352	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HES1—lung cancer	8.87e-05	0.000348	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—BRAF—lung cancer	8.85e-05	0.000348	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—RAF1—lung cancer	8.81e-05	0.000346	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—RAF1—lung cancer	8.78e-05	0.000345	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6R—lung cancer	8.75e-05	0.000343	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CREBBP—lung cancer	8.73e-05	0.000343	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—IL2—lung cancer	8.7e-05	0.000342	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—RAF1—lung cancer	8.7e-05	0.000342	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—IL2—lung cancer	8.67e-05	0.000341	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOA1—lung cancer	8.66e-05	0.00034	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PIK3CB—lung cancer	8.6e-05	0.000338	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—IL2—lung cancer	8.59e-05	0.000337	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—EGFR—lung cancer	8.58e-05	0.000337	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PIK3CB—lung cancer	8.57e-05	0.000337	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3CB—lung cancer	8.49e-05	0.000334	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAP2K1—lung cancer	8.33e-05	0.000327	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CD—lung cancer	8.28e-05	0.000325	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CXCL8—lung cancer	8.27e-05	0.000325	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CXCL8—lung cancer	8.24e-05	0.000324	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ERBB3—lung cancer	8.21e-05	0.000323	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—PIK3CA—lung cancer	8.2e-05	0.000322	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ERBB3—lung cancer	8.19e-05	0.000322	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CXCL8—lung cancer	8.16e-05	0.00032	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ERBB3—lung cancer	8.11e-05	0.000318	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—KRAS—lung cancer	8.11e-05	0.000318	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CG—lung cancer	7.91e-05	0.000311	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL2—lung cancer	7.9e-05	0.00031	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL2—lung cancer	7.87e-05	0.000309	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TERT—lung cancer	7.87e-05	0.000309	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TERT—lung cancer	7.85e-05	0.000308	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL2—lung cancer	7.8e-05	0.000306	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TERT—lung cancer	7.77e-05	0.000305	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FGFR1—lung cancer	7.64e-05	0.0003	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FGFR1—lung cancer	7.62e-05	0.000299	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FGFR1—lung cancer	7.54e-05	0.000296	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HIF1A—lung cancer	7.53e-05	0.000296	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—POMC—lung cancer	7.53e-05	0.000296	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HIF1A—lung cancer	7.5e-05	0.000295	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—PIK3CA—lung cancer	7.45e-05	0.000293	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HIF1A—lung cancer	7.43e-05	0.000292	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MDM2—lung cancer	7.42e-05	0.000291	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RAF1—lung cancer	7.39e-05	0.00029	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CREBBP—lung cancer	7.33e-05	0.000288	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ERBB2—lung cancer	7.31e-05	0.000287	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOA1—lung cancer	7.26e-05	0.000285	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOA1—lung cancer	7.24e-05	0.000284	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MTOR—lung cancer	7.22e-05	0.000283	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CB—lung cancer	7.22e-05	0.000283	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KDR—lung cancer	7.2e-05	0.000283	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KDR—lung cancer	7.18e-05	0.000282	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOA1—lung cancer	7.17e-05	0.000282	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KDR—lung cancer	7.11e-05	0.000279	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CD—lung cancer	6.95e-05	0.000273	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCL8—lung cancer	6.94e-05	0.000272	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—HRAS—lung cancer	6.89e-05	0.000271	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ALB—lung cancer	6.86e-05	0.000269	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—AKT1—lung cancer	6.7e-05	0.000263	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CASP3—lung cancer	6.64e-05	0.000261	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APC—lung cancer	6.63e-05	0.00026	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KIT—lung cancer	6.63e-05	0.00026	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CG—lung cancer	6.63e-05	0.00026	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—NRAS—lung cancer	6.63e-05	0.00026	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL2—lung cancer	6.63e-05	0.00026	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APC—lung cancer	6.61e-05	0.00026	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CG—lung cancer	6.61e-05	0.00026	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KIT—lung cancer	6.61e-05	0.00026	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—NRAS—lung cancer	6.61e-05	0.00026	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL6—lung cancer	6.59e-05	0.000259	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EGF—lung cancer	6.56e-05	0.000257	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APC—lung cancer	6.55e-05	0.000257	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CG—lung cancer	6.55e-05	0.000257	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KIT—lung cancer	6.55e-05	0.000257	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—NRAS—lung cancer	6.55e-05	0.000257	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EGF—lung cancer	6.53e-05	0.000257	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EGF—lung cancer	6.47e-05	0.000254	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCND1—lung cancer	6.46e-05	0.000254	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—JUN—lung cancer	6.45e-05	0.000253	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—MAPK3—lung cancer	6.35e-05	0.000249	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—MAPK3—lung cancer	6.33e-05	0.000249	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—POMC—lung cancer	6.31e-05	0.000248	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—POMC—lung cancer	6.29e-05	0.000247	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MMP9—lung cancer	6.27e-05	0.000246	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—MAPK3—lung cancer	6.27e-05	0.000246	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CDKN1A—lung cancer	6.25e-05	0.000245	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PTEN—lung cancer	6.24e-05	0.000245	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—BRAF—lung cancer	6.23e-05	0.000245	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—POMC—lung cancer	6.23e-05	0.000245	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—BRAF—lung cancer	6.21e-05	0.000244	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6R—lung cancer	6.16e-05	0.000242	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—BRAF—lung cancer	6.15e-05	0.000242	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CREBBP—lung cancer	6.15e-05	0.000241	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6R—lung cancer	6.14e-05	0.000241	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CREBBP—lung cancer	6.13e-05	0.000241	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—AKT1—lung cancer	6.08e-05	0.000239	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6R—lung cancer	6.08e-05	0.000239	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CREBBP—lung cancer	6.07e-05	0.000238	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CB—lung cancer	6.06e-05	0.000238	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—EGFR—lung cancer	6.04e-05	0.000237	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—EGFR—lung cancer	6.02e-05	0.000237	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTGS2—lung cancer	6e-05	0.000236	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—EGFR—lung cancer	5.96e-05	0.000234	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—EP300—lung cancer	5.95e-05	0.000234	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAP2K1—lung cancer	5.87e-05	0.00023	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAP2K1—lung cancer	5.85e-05	0.00023	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CD—lung cancer	5.83e-05	0.000229	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CD—lung cancer	5.81e-05	0.000228	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAP2K1—lung cancer	5.79e-05	0.000228	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SRC—lung cancer	5.78e-05	0.000227	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PIK3CA—lung cancer	5.77e-05	0.000227	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PIK3CA—lung cancer	5.76e-05	0.000226	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CD—lung cancer	5.75e-05	0.000226	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—KRAS—lung cancer	5.71e-05	0.000224	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	5.7e-05	0.000224	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—KRAS—lung cancer	5.69e-05	0.000223	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—KRAS—lung cancer	5.63e-05	0.000221	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—VEGFA—lung cancer	5.63e-05	0.000221	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—STAT3—lung cancer	5.58e-05	0.000219	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NRAS—lung cancer	5.56e-05	0.000219	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAPK3—lung cancer	5.33e-05	0.000209	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PIK3CA—lung cancer	5.24e-05	0.000206	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTEN—lung cancer	5.23e-05	0.000206	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PIK3CA—lung cancer	5.23e-05	0.000205	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MDM2—lung cancer	5.22e-05	0.000205	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MDM2—lung cancer	5.21e-05	0.000204	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RAF1—lung cancer	5.2e-05	0.000204	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RAF1—lung cancer	5.19e-05	0.000204	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MYC—lung cancer	5.18e-05	0.000204	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	5.18e-05	0.000203	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MDM2—lung cancer	5.16e-05	0.000202	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ERBB2—lung cancer	5.15e-05	0.000202	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RAF1—lung cancer	5.14e-05	0.000202	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ERBB2—lung cancer	5.13e-05	0.000202	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ERBB2—lung cancer	5.08e-05	0.0002	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MTOR—lung cancer	5.08e-05	0.0002	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CB—lung cancer	5.08e-05	0.0002	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—EGFR—lung cancer	5.07e-05	0.000199	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MTOR—lung cancer	5.07e-05	0.000199	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CB—lung cancer	5.07e-05	0.000199	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MTOR—lung cancer	5.02e-05	0.000197	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CB—lung cancer	5.02e-05	0.000197	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—EP300—lung cancer	4.99e-05	0.000196	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL8—lung cancer	4.88e-05	0.000192	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL8—lung cancer	4.87e-05	0.000191	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HRAS—lung cancer	4.85e-05	0.000191	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HRAS—lung cancer	4.84e-05	0.00019	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL8—lung cancer	4.82e-05	0.000189	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HRAS—lung cancer	4.79e-05	0.000188	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—KRAS—lung cancer	4.79e-05	0.000188	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—AKT1—lung cancer	4.72e-05	0.000185	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—AKT1—lung cancer	4.7e-05	0.000185	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CASP3—lung cancer	4.67e-05	0.000184	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL2—lung cancer	4.67e-05	0.000183	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CASP3—lung cancer	4.66e-05	0.000183	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—AKT1—lung cancer	4.66e-05	0.000183	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL2—lung cancer	4.65e-05	0.000183	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6—lung cancer	4.64e-05	0.000182	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6—lung cancer	4.63e-05	0.000182	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CASP3—lung cancer	4.61e-05	0.000181	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL2—lung cancer	4.61e-05	0.000181	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6—lung cancer	4.58e-05	0.00018	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCND1—lung cancer	4.55e-05	0.000179	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—JUN—lung cancer	4.54e-05	0.000178	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCND1—lung cancer	4.53e-05	0.000178	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—JUN—lung cancer	4.53e-05	0.000178	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCND1—lung cancer	4.49e-05	0.000176	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—JUN—lung cancer	4.48e-05	0.000176	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MMP9—lung cancer	4.42e-05	0.000173	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MMP9—lung cancer	4.4e-05	0.000173	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CDKN1A—lung cancer	4.4e-05	0.000173	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PIK3CA—lung cancer	4.4e-05	0.000173	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTEN—lung cancer	4.39e-05	0.000172	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CDKN1A—lung cancer	4.39e-05	0.000172	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTEN—lung cancer	4.38e-05	0.000172	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MMP9—lung cancer	4.36e-05	0.000171	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CDKN1A—lung cancer	4.34e-05	0.000171	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTEN—lung cancer	4.33e-05	0.00017	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AKT1—lung cancer	4.28e-05	0.000168	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AKT1—lung cancer	4.27e-05	0.000168	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TP53—lung cancer	4.26e-05	0.000167	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AKT1—lung cancer	4.23e-05	0.000166	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EP300—lung cancer	4.19e-05	0.000164	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EP300—lung cancer	4.17e-05	0.000164	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EP300—lung cancer	4.13e-05	0.000162	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SRC—lung cancer	4.07e-05	0.00016	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HRAS—lung cancer	4.07e-05	0.00016	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SRC—lung cancer	4.06e-05	0.000159	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SRC—lung cancer	4.02e-05	0.000158	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—VEGFA—lung cancer	3.97e-05	0.000156	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—VEGFA—lung cancer	3.95e-05	0.000155	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—STAT3—lung cancer	3.93e-05	0.000154	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NRAS—lung cancer	3.92e-05	0.000154	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—VEGFA—lung cancer	3.92e-05	0.000154	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—STAT3—lung cancer	3.91e-05	0.000154	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NRAS—lung cancer	3.91e-05	0.000153	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6—lung cancer	3.9e-05	0.000153	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—STAT3—lung cancer	3.88e-05	0.000152	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NRAS—lung cancer	3.87e-05	0.000152	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAPK3—lung cancer	3.75e-05	0.000147	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAPK3—lung cancer	3.74e-05	0.000147	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAPK3—lung cancer	3.7e-05	0.000145	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PIK3CA—lung cancer	3.69e-05	0.000145	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MYC—lung cancer	3.65e-05	0.000143	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MYC—lung cancer	3.64e-05	0.000143	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MYC—lung cancer	3.6e-05	0.000141	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AKT1—lung cancer	3.59e-05	0.000141	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EGFR—lung cancer	3.57e-05	0.00014	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EGFR—lung cancer	3.56e-05	0.00014	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EGFR—lung cancer	3.52e-05	0.000138	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KRAS—lung cancer	3.37e-05	0.000132	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KRAS—lung cancer	3.36e-05	0.000132	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KRAS—lung cancer	3.33e-05	0.000131	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PIK3CA—lung cancer	3.1e-05	0.000122	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PIK3CA—lung cancer	3.09e-05	0.000121	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PIK3CA—lung cancer	3.06e-05	0.00012	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AKT1—lung cancer	3.02e-05	0.000118	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TP53—lung cancer	3e-05	0.000118	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TP53—lung cancer	2.99e-05	0.000117	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TP53—lung cancer	2.96e-05	0.000116	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HRAS—lung cancer	2.87e-05	0.000113	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HRAS—lung cancer	2.86e-05	0.000112	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HRAS—lung cancer	2.83e-05	0.000111	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6—lung cancer	2.74e-05	0.000108	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6—lung cancer	2.73e-05	0.000107	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6—lung cancer	2.71e-05	0.000106	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AKT1—lung cancer	2.53e-05	9.94e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AKT1—lung cancer	2.52e-05	9.91e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AKT1—lung cancer	2.5e-05	9.81e-05	CbGpPWpGaD
